JP
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in Switzerland | Kidney International Reports | 2025 | 43 | 56 | |||
Allogeneic hematopoietic stem cell transplantation in non-Hodgkin lymphoma in Switzerland, 30 years of experience : Sooner is better | EJHaem | 2023 | 54 | 27 | |||
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 201 | 74 | |||
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP | European Journal of Haematology | 2020 | 137 | 0 | |||
Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients | Open Forum Infectious Diseases | 2020 | 440 | 117 | |||
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial | Blood Advances | 2020 | 252 | 119 | |||
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT | British Journal of Haematology | 2020 | 178 | 0 | |||
Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study | Transplant Infectious Disease | 2020 | 377 | 2 | |||
Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis | Haematologica | 2019 | 346 | 116 | |||
High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation | Bone Marrow Transplantation | 2019 | 425 | 102 | |||
Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a retrospective study by the EBMT chronic malignancies working party | Biology of Blood and Marrow Transplantation | 2019 | 241 | 0 | |||
Family mismatched allogeneic stem cell transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of EBMT | Biology of Blood and Marrow Transplantation | 2018 | 377 | 0 | |||
Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study | Transplant Infectious Disease | 2018 | 443 | 0 | |||
Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study | Bone Marrow Transplantation | 2017 | 268 | 0 | |||
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML | Blood | 2017 | 469 | 0 | |||
Obstacles to Widening Biosample Research | Science and Engineering Ethics | 2017 | 370 | 389 | |||
Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison | Nutrition | 2017 | 509 | 1 | |||
Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow | Leukemia | 2015 | 616 | 375 | |||
Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies | Bone marrow research | 2015 | 558 | 107 | |||
Comparing Two Types of Rabbit ATG prior to Reduced Intensity Conditioning Allogeneic Hematopoietic SCT for Hematologic Malignancies | Bone marrow research | 2015 | 666 | 301 | |||
Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis | Biology of blood and marrow transplantation | 2014 | 572 | 1 | |||
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT | Haematologica | 2014 | 552 | 587 | |||
Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07) | Leukemia & lymphoma | 2014 | 692 | 1,266 | |||
Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries | Schweizerische medizinische Wochenschrift | 2013 | 646 | 1 | |||
Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial | PloS one | 2013 | 741 | 209 | |||
Is acute fibrinous and organizing pneumonia the expression of immune dysregulation? | Journal of pediatric hematology/oncology | 2013 | 807 | 0 | |||
Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations | Transfusion medicine and hemotherapy | 2013 | 624 | 475 | |||
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study | Journal of clinical oncology | 2013 | 1,339 | 1,319 | |||
Initial cord blood unit volume affects mononuclear cell and CD34+ cell-processing efficiency in a non-linear fashion | Cytotherapy | 2012 | 694 | 0 | |||
Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation | Pediatric transplantation | 2012 | 703 | 0 | |||
Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT | Bone marrow transplantation | 2012 | 770 | 0 | |||
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | 2011 | 1,010 | 582 | |||
Do NK cells contribute to the pathophysiology of transplant-associated thrombotic microangiopathy? | American journal of transplantation | 2011 | 696 | 0 | |||
Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation | European journal of haematology | 2011 | 650 | 0 | |||
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | 2011 | 846 | 8 | |||
Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation | Haematologica | 2011 | 601 | 0 | |||
Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity | Cell transplantation | 2011 | 674 | 0 | |||
Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow | Blood | 2011 | 677 | 1 | |||
Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal | Bone marrow transplantation | 2011 | 577 | 0 | |||
Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms | Biology of blood and marrow transplantation | 2011 | 613 | 0 | |||
Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA | British journal of haematology | 2010 | 495 | 0 | |||
Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe. A report of The EBMT aplastic anaemia working party | British journal of haematology | 2010 | 561 | 0 | |||
Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors | Haematologica | 2010 | 495 | 0 | |||
Hematopoietic stem cell transplantation in Switzerland: a comprehensive quality control report on centre effect | Schweizerische medizinische Wochenschrift | 2010 | 544 | 0 | |||
Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party | British journal of haematology | 2010 | 514 | 0 | |||
Anamie bei Knochenmarksaplasie, paroxysmaler nachtlicher Hamoglobinurie und Myelodysplastischen Syndromen | Therapeutische Umschau | 2010 | 517 | 0 | |||
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT | Bone marrow transplantation | 2010 | 530 | 0 | |||
[Anemia as it appears to the Internist] | Therapeutische Umschau | 2010 | 454 | 0 | |||
Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection | Transplant infectious disease | 2010 | 688 | 0 | |||
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion | Journal of immunotherapy | 2010 | 569 | 0 | |||
Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies | Bone marrow transplantation | 2010 | 594 | 0 | |||
Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation | Acta haematologica | 2010 | 584 | 0 | |||
Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients | Haematologica | 2010 | 569 | 1 | |||
IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA | European Journal of Immunology | 2010 | 586 | 1 | |||
Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood | International journal of laboratory hematology | 2010 | 557 | 0 | |||
CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells | European Journal of Immunology | 2010 | 651 | 0 | |||
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party | Haematologica | 2010 | 648 | 0 | |||
Acute disseminated fatal toxoplasmosis after haploidentical stem cell transplantation despite atovaquone prophylaxis in a young man | The Pediatric infectious disease journal | 2010 | 625 | 0 | |||
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 | Bone marrow transplantation | 2010 | 641 | 0 | |||
Invasive microsporidiosis in allogeneic haematopoietic SCT recipients | Bone marrow transplantation | 2010 | 548 | 0 | |||
Tumors that look for their springtime in APRIL | Critical reviews in oncology/hematology | 2009 | 640 | 0 | |||
Birth order and outcome after HLA-identical sibling donor transplantation | Blood | 2009 | 461 | 0 | |||
Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation | Pediatric transplantation | 2009 | 467 | 0 | |||
Hodgkin's lymphoma relapsing after autologous transplantation: allogeneic hematopoietic stem cell transplantation using a strategy of reduced intensity conditioning, and T-cell depletion with T-cell add-back | European journal of haematology | 2009 | 569 | 0 | |||
Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia | Biology of blood and marrow transplantation | 2009 | 580 | 0 | |||
Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells | Bone marrow transplantation | 2009 | 649 | 0 | |||
Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortality | European journal of haematology | 2009 | 495 | 0 | |||
Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA | British journal of haematology | 2009 | 505 | 0 | |||
In situ detection of APRIL-rich niches for plasma-cell survival and their contribution to B-cell lymphoma development | Histology and histopathology | 2009 | 577 | 0 | |||
Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation | Transfusion | 2009 | 557 | 0 | |||
Aplastic anemia and concomitant autoimmune diseases | Annals of hematology | 2009 | 628 | 0 | |||
DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study | European journal of haematology | 2009 | 517 | 0 | |||
Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins | Haematologica | 2009 | 572 | 0 | |||
Atypical presentation of acute myeloid leukemia: cardiac myeloid sarcoma | International journal of hematology | 2009 | 614 | 0 | |||
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis | Cancer | 2009 | 525 | 0 | |||
Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling? | Haematologica | 2009 | 511 | 0 | |||
Diagnosis and treatment of acquired aplastic anemia | Hematology/oncology clinics of North America | 2009 | 587 | 0 | |||
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome | Haematologica | 2009 | 558 | 0 | |||
Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen | Haematologica | 2009 | 465 | 0 | |||
Quality of life and social integration after allogeneic hematopoietic SCT | Bone marrow transplantation | 2008 | 593 | 0 | |||
In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them | Journal of cellular physiology | 2008 | 637 | 7 | |||
Les leucémies aiguës | Revue médicale suisse | 2008 | 531 | 2 | |||
Reconstitution of the immune system after hematopoietic stem cell transplantation in humans | Seminars in immunopathology | 2008 | 552 | 434 | |||
Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases | Experimental hematology | 2008 | 584 | 0 | |||
Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantation | Bone marrow transplantation | 2008 | 530 | 0 | |||
The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable | Bone marrow transplantation | 2007 | 512 | 0 |